← Leaderboards
Jason B Fleming
University Of Texas Sw Med Ctr/Dallas
$1,664,059
Attributed
$1,664,059
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $702.9K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,664,059 · 3
By mechanism
U54$1,453,459 · 2
R21$210,600 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Madhukar H Trivedi$36,286,053
- Chandra Mohan$22,970,871
- Thomas M Wilkie$3,582,679
- Joachim J Herz$19,473,068
Others in their field
Top investigators on “Malignant Neoplasm Of Pancreas”
- David Heimbrook · Leidos Biomedical Research, Inc.$73,277,592
- Anirban Maitra · Johns Hopkins University$43,028,398
- Walter John Curran · Thomas Jefferson University$26,641,549
- Surinder Kumar Batra · University Of Pittsburgh At Pittsburgh$26,074,679
- Michael A Hollingsworth · University Of Nebraska Medical Center$23,837,917
- Robert E Reiter · University Of California Los Angeles$21,473,394
Research focus
Malignant Neoplasm Of PancreasBaseResistanceTumorDesignCoupledExhibitsPancreatic Ductal AdenocarcinomaResponseTumor MicroenvironmentMolecularCancer CenterBiological ModelsClinical TrialsBiological MarkersBiological HeterogeneityAnticancer ActivityCohortCancer TherapyClinical PredictorsCancer InitiationCancer Therapy Evaluation ProgramCdk4 GeneClinically Relevant
Grant awards (8)
Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer$250,509
U54 · FY2019 · CA · contact PI
Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer$8,571
U54 · FY2019 · CA · contact PI
Microenvironmental Transport for Immunotherapy in Pancreatic Cancer$238,528
U54 · FY2018 · CA · contact PI
Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer$483,810
U54 · FY2017 · CA · contact PI
Microenvironmental Transport for Immunotherapy in Pancreatic Cancer$219,101
U54 · FY2017 · CA · contact PI
Microenvironmental Transport for Immunotherapy in Pancreatic Cancer$252,940
U54 · FY2016 · CA · contact PI
VEGF Promotes Pancreatic Tumor Cell Arrest in the Liver$105,300
R21 · FY2005 · CA
VEGF Promotes Pancreatic Tumor Cell Arrest in the Liver$105,300
R21 · FY2004 · CA